CRISPR From Research To Therapy
Source: Lonza

The recent approval of the first non-viral CRISPR-based gene therapy once again underlines the therapeutic and life-changing potential of this groundbreaking genome editing technology.
Benefit from the knowledge and protocols published by your peers for implementing CRISPR or other genome editing techniques into your research and manufacturing. Learn from our selection of scientific publications how researchers have been using the Nucleofector® Electroporation Technology for genome editing applications for more than a decade.
Download our Genome Editing Publication List:
- Comprising 180+ selected publications
- Covering tools from CRISPR/Cas9, to TALEN®, ZFN and Sleeping Beauty® or PiggyBac® transposon/transposase
- Including latest advancements like prime and base editing
- Comprehensibly sorted by technology
access the Datasheet!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
This website uses cookies to ensure you get the best experience on our website. Learn more